Therapeutic drug development program for COVID-19 (COVID-DMC)

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2020
This article has no abstract
Epistemonikos ID: 74de06474d747bc8e1a84317085075cabe3d901c
First added on: Sep 10, 2020